Literature DB >> 6715399

Diagnosis and staging of ovarian cancer.

A Pfleiderer.   

Abstract

The diagnostic process in ovarian carcinoma is divided into the pre- and intraoperative procedures, examinations of tumor tissue, and follow-up. For preoperative diagnosis, the probability of a palpable adnexal mass being a malignant tumor should first be ascertained by sonography. This should be followed by an appropriate general examination, a search for tumor outside the abdominal cavity and in the liver parenchyma as well as by determination of markers. Intraoperative diagnosis determines the tumor stage and must be carried out all the more comprehensively when the ovarian carcinoma is more limited. Histologic subtype and degree of differentiation are in direct relation to the tumor stage, whereas the size of the primary tumor is often indirectly proportional to its extent. Besides the morphological analysis, the determination of possible chemoresistance and chemosensitivity, as well as further investigations on fresh tumor tissue are included in the tissue examination. Follow-up after a curative operation consists of gynecologic examination and Douglas lavages if tumor is still present in CT Scans and sonographs. To verify a relapse, laparoscopy can be used, but to ascertain a complete remission, a laparotomy is necessary.

Entities:  

Mesh:

Year:  1984        PMID: 6715399     DOI: 10.1007/bf00399376

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Histologic grade in advanced ovarian cancer.

Authors:  R F Ozols; A J Garvin; J Costa; R M Simon; R C Young
Journal:  Cancer Treat Rep       Date:  1979-02

2.  The histology and histogenesis of ovarian neoplasia.

Authors:  J D Woodruff; R W TeLinde
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

3.  [Selective tumour chemotherapy using oncobiograms (author's transl)].

Authors:  M Volm; M Kaufmann; K Wayss; K Goerttler; J Mattern
Journal:  Dtsch Med Wochenschr       Date:  1974-01-11       Impact factor: 0.628

4.  Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer.

Authors:  H R Barber; S C Sommers; R Synder; T H Kwon
Journal:  Am J Obstet Gynecol       Date:  1975-03-15       Impact factor: 8.661

5.  [Function-saving surgical treatment of degenerative and neoplastic diseases of the ovaries].

Authors:  P Kolstad
Journal:  Gynakologe       Date:  1980-09

6.  Can computed tomography substitute for second-look operation in ovarian carcinoma?

Authors:  J Stern; J Buscema; N Rosenshein; S Siegelman
Journal:  Gynecol Oncol       Date:  1981-02       Impact factor: 5.482

7.  Retroperitoneal metastases from ovarian carcinoma: reassessment of 365 patients studied with lymphography.

Authors:  R Musumeci; G De Palo; R Kenda; J D Tesoro-Tess; F Di Re; R Petrillo; F Rilke
Journal:  AJR Am J Roentgenol       Date:  1980-03       Impact factor: 3.959

8.  [Testing of sensitivity of human tumours to cytostatics in a rapid in vitro test (author's transl)].

Authors:  M Volm
Journal:  Dtsch Med Wochenschr       Date:  1980-10-24       Impact factor: 0.628

9.  Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute.

Authors:  J P Smith; T G Day
Journal:  Am J Obstet Gynecol       Date:  1979-12-01       Impact factor: 8.661

10.  Surgery for common epithelial tumors of the ovary.

Authors:  J T Wharton; J Herson
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

View more
  3 in total

1.  Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator.

Authors:  M-C Chang; Y-L Chen; Y-C Chiang; T-C Chen; Y-C Tang; C-A Chen; W-Z Sun; W-F Cheng
Journal:  Gene Ther       Date:  2015-08-11       Impact factor: 5.250

2.  High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma.

Authors:  W-F Cheng; C-Y Huang; M-C Chang; Y-H Hu; Y-C Chiang; Y-L Chen; C-Y Hsieh; C-A Chen
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

3.  Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses.

Authors:  Yu-Li Chen; Ming-Cheng Chang; Chi-An Chen; Han-Wei Lin; Wen-Fang Cheng; Chung-Liang Chien
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.